Table 3.
VH gene family distribution in peripheral B cells from SLE and SS patients and healthy controls
Expected frequency | 2 Normal CD5- /IgM+ B cells [33] |
1 SLE patient [29] |
1 SS patient [39] |
||||
---|---|---|---|---|---|---|---|
non-productive (%) |
Productive (%) |
non-productive (%) |
Productive (%) | non-productive (%) |
Productive (%) |
||
VH1 | 21.6 | 4.0 | 13.1a | 0 | 2.4 | 16.7 | 24.7 |
VH2 | 5.9 | 8.0 | 1.9 | 16.7 | 7.3 | - | 3.1 |
VH3 | 43.1 | 36.0 | 53.9a | 66.7 | 82.9b | 44.4 | 46.4 |
VH4 | 21.6 | 44.0a | 24.8 | 16.7 | 7.3b | 22.2 | 15.5 |
VH5 | 3.9 | 4.0 | 2.9 | 0 | 0 | 5.6 | 9.3 |
VH6 | 2.0 | 4.0 | 2.4 | 0 | 0 | 11.1 | 1.0 |
VH7 | 2.0 | 0 | 1.0 | 0 | 0 | - | - |
significantly different from expected frequency
significantly different from normal values
Bold numbers indicate significant differences between the productive and the non-productive repertoire Note that there were no significant differences between the productive and the non-productive repertoire of the SS patient or between either of these repertoires and those of healthy controls